HLA-G and colorectal carcinoma: In a joint analysis of HLA class I, HLA-E, and HLA-G to predict the prognosis of colorectal cancer (CRC), three tumor immune phenotypes are generated by comprehensively analyzing the expressions of all markers, resulting in strong immune system tumor recognition, intermediate immune system tumor recognition, and poor immune system tumor recognition.